These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14519648)

  • 1. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth.
    Biancone L; Cantaluppi V; Del Sorbo L; Russo S; Tjoelker LW; Camussi G
    Clin Cancer Res; 2003 Sep; 9(11):4214-20. PubMed ID: 14519648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase.
    Doublier S; Ceretto M; Lupia E; Bravo S; Bussolati B; Camussi G
    Clin Cancer Res; 2007 Oct; 13(19):5710-8. PubMed ID: 17908960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
    Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet-activating factor receptor expression on CHO cell motility.
    Boccellino M; Biancone L; Cantaluppi V; Ye RD; Camussi G
    J Cell Physiol; 2000 May; 183(2):254-64. PubMed ID: 10737901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.
    Heon Seo K; Ko HM; Kim HA; Choi JH; Jun Park S; Kim KJ; Lee HK; Im SY
    Cancer Res; 2006 May; 66(9):4681-6. PubMed ID: 16651419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism for regulation of plasma platelet-activating factor acetylhydrolase expression in mammalian cells.
    Gardner AA; Reichert EC; Alexander TS; Topham MK; Stafforini DM
    Biochem J; 2010 May; 428(2):269-79. PubMed ID: 20331434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
    Satoh K
    Brain Nerve; 2008 Nov; 60(11):1319-24. PubMed ID: 19069165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of platelet activating factor-acetyl hydrolase (PAF-AH) in the salivary glands of Rhodnius prolixus.
    Côrte-Real R; Gomes RN; Castro-Faria-Neto HC; Azambuja P; Garcia ES
    J Insect Physiol; 2011 Jun; 57(6):825-9. PubMed ID: 21439293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters.
    Bathgate R; Maxwell WM; Evans G
    Theriogenology; 2007 Mar; 67(4):886-92. PubMed ID: 17157372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates.
    Quistad GB; Fisher KJ; Owen SC; Klintenberg R; Casida JE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):149-56. PubMed ID: 15893542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.
    Bussolati B; Biancone L; Cassoni P; Russo S; Rola-Pleszczynski M; Montrucchio G; Camussi G
    Am J Pathol; 2000 Nov; 157(5):1713-25. PubMed ID: 11073830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection.
    Seki M; Kosai K; Hara A; Imamura Y; Nakamura S; Kurihara S; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Miyazaki Y; Mukae H; Tashiro T; Kohno S
    Jpn J Infect Dis; 2009 Jan; 62(1):6-10. PubMed ID: 19168951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor.
    Melnikova V; Bar-Eli M
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):359-71. PubMed ID: 17721743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: relevance for islet transplantation.
    Biancone L; Cantaluppi V; Romanazzi GM; Russo S; Figliolini F; Beltramo S; Scalabrino E; Deregibus MC; Romagnoli R; Franchello A; Salizzoni M; Perin PC; Ricordi C; Segoloni GP; Camussi G
    Transplantation; 2006 Feb; 81(4):511-8. PubMed ID: 16495796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
    Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
    J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
    Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
    Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
    Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J
    Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
    Gomes RN; Bozza FA; Amâncio RT; Japiassú AM; Vianna RC; Larangeira AP; Gouvêa JM; Bastos MS; Zimmerman GA; Stafforini DM; Prescott SM; Bozza PT; Castro-Faria-Neto HC
    Shock; 2006 Jul; 26(1):41-9. PubMed ID: 16783197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.